Spend Too Much On Your Medications? Help Is On The Way

How is a physician supposed to know which medicine is most affordable under which insurance plan?

Fortunately, there are tools coming into use designed to help clinicians figure out patient-specific costs of any medication they prescribe. The tools (jargon alert!) are called RTBTs, for real-time benefit tools.

Read More
Regulating Surprise Bills Lower Healthcare Prices – Guess How Much

You wake up in the post-operative recovery area, still groggy, the full effects of the procedure obscured by an anesthetic haze. You begin to ponder several questions: Was the surgery a success? Did the surgeon find anything unexpected? How quickly will the procedure make you feel better?

There’s another question you might ask yourself. A few weeks from now, is anyone involved in your care going to send you a surprise bill?

Read More
Pandemics and Overdoses: COVID-19 May Worsen Our Opioid Epidemic

The novel coronavirus has decimated our economy at the same time as it has directly threatened our health. As if that weren’t bad enough, the economic damage Covid-19 is causing could have an indirect impact on our health. Consider what we already know about economic downturns and opioid overdoses. A research team led by Atheendar […]

Read More
Critics Wonder Whether the FDA Is Too Slow to Handle a Pandemic

The FDA plays a critical role in our nation’s response to the COVID-19 pandemic. It helps decide which medicines are safe and effective to treat the disease. It evaluates the accuracy and reliability of laboratory tests. And it will play a central role in assessing potential vaccines. But will the FDA bureaucracy move with the […]

Read More
Science Isn’t Meant To Be Followed

Science cannot lead us out of this pandemic. Whatever paths we take to navigate COVID-19 need to be chosen through political processes. The true role of science is to illuminate these pathways, guiding our policy choices by showing us what’s at stake.

Read More

PeterUbel